Today: 9 June 2026
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan
9 June 2026
1 min read

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

New York, June 8, 2026, 19:02 (EDT)

  • Mingteng International finished the session at $1.94, jumping 81.3%. Shares traded between $1.05 and $5.34 as volume spiked.
  • The company said it ended an at-the-market stock sale plan after raising roughly $20.6 million in gross proceeds from the share sales.
  • The move outpaced gains in other U.S.-listed China auto stocks.

Mingteng International Corporation Inc. (Nasdaq) soared 81.3% Monday. The China automotive mold supplier announced after the jump that it ended its at-the-market share sale program, pulling in about $20.6 million in gross proceeds. An at-the-market, or ATM, program gives companies a way to sell stock gradually instead of all at once.

Mingteng said in a filing the sales pact with AC Sunshine Securities ended June 8, after it sold 222,568,877 Class A ordinary shares under its ATM program. That number doesn’t account for the 1-for-200 reverse split in January. The company reported net proceeds were around $18.0 million.

MTEN is a microcap, with a market cap of just a few million dollars, so thin trading, float changes or new stock can send the price moving fast. On Monday, shares changed hands 24.2 million times. That’s against a market value of roughly $12.0 million, according to the latest quote feed.

Tech and chip stocks bounced back Monday, sending the Nasdaq Composite up 0.86%. The S&P 500 was also up, gaining 0.30%, according to Reuters. The move in the Nasdaq was bigger than the broader rally.

Mingteng’s rally was sharp compared with other U.S.-listed Chinese auto and tech stocks. Shares of China Automotive Systems were up 1.1%, Kandi Technologies added 4.8%, and Hesai Group gained 3.5%. Those moves looked minor next to MTEN’s one-day jump.

Mingteng makes molds for auto parts, such as casting molds for turbochargers, braking, steering, and differential systems. The company also produces products for new-energy EV systems. Its plants are in Wuxi, China.

The company has reworked its share structure this year. Back in January, it did a 1-for-200 reverse stock split, merging every 200 shares into one. The ticker MTEN stayed on the Nasdaq Capital Market. Low-priced stocks often use reverse splits to boost share price, but it doesn’t affect the company’s total value.

Mingteng said in January it finished moving to a new production site and aimed to boost mold output capacity by 50%. Chairman and CEO Yingkai Xu described the move as a “key milestone” for the firm’s medium- and long-term plans.

Mingteng posted a 15.3% jump in 2025 revenue to $11.7 million, helped by mold production and machining, but still reported a net loss of $1.8 million. Gross margin dropped to 22.5% from 30.3% last year as material, labor and manufacturing costs climbed. The overall picture remains mixed.

Stock action could be getting ahead of the actual business. Monday saw a big swing. The company is still small. Its latest filing pointed to past share sales, not fresh orders, not a new bump to earnings. Mingteng has a tight customer base: two buyers made up about 22.1% and 18.4% of 2025 revenue, according to its annual report.

Stock Market Today

  • Elevance Health Stock Quote Price and Forecast
    June 8, 2026, 9:14 PM EDT. Elevance Health Inc. is a health company focused on improving healthcare through its segments: Health Benefits, CarelonRx (pharmacy services), Carelon Services (integrated health services), and Corporate and Other. The Health Benefits segment provides a broad suite of plans, while CarelonRx serves both affiliated and external customers with pharmacy services. Carelon Services aims to deliver affordable whole health by integrating physical, behavioral, pharmacy, and social services. Founded in 1944, Elevance Health is headquartered in Indianapolis and focuses on simplifying healthcare and community health improvement.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms
Previous Story

Peso Rebounds, But Mexico’s Next Inflation Print Looms

Why Novo Nordisk Stock Fell Even After Wegovy Pill Hit 3 Million Prescriptions
Next Story

Why Novo Nordisk Stock Fell Even After Wegovy Pill Hit 3 Million Prescriptions

Go toTop